Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Sedigheh Tahereh Research Complex, Khorram Street, Isfahan, 8187698191, Iran.
Isfahan Endocrine and Metabolism Research Center, Isfahan, Iran.
Eur J Med Res. 2017 Jun 21;22(1):21. doi: 10.1186/s40001-017-0260-2.
The prevalence of thyroid dysfunction is high in Isfahan, an area of iodine sufficient in Iran. The aim of this study is to investigate the incidence of thyroid dysfunctions in adults of metropolitan Isfahan and to determine the role of thyroid autoantibodies.
In a population-based cohort study in 2006-2011, we measured TSH, T4, T3, thyroid peroxidase antibody (TPOAb), and thyroglobulin antibody (TgAb) in 618 out of 2254 people who were euthyroid in 2006. The incidence rates per 1000 person-year (pr) were calculated. The odds ratio (OR), relative risk (RR), and 95% confidence interval (95% CI) were calculated based on logistic regression to quantify the potential predictors of thyroid dysfunction. The receiver-operator characteristic (ROC) analysis along with area under the curve (AUC) was used to determine the optimal cutoff values for baseline TPOAb and TgAb as predictors of thyroid dysfunction.
Within a 6-year follow-up, the incidence rate of hypothyroidism was 3.3 in women and 2.1 in men while the incidence rate of hyperthyroidism was 3.8 in women and none in men per 1000 (person-year). A cutoff value of TPOAb at 38 IU/mL was obtained to differentiate the patients with hypothyroidism and hyperthyroidism, with specificity of 0.75 and sensitivity of 0.76, and AUC (CI 95%) of 0.882 (0.743-1.02), P = 0.01 and 0.817 (0.600-1.035) P = 0.033, respectively. There is a statistically significant association of hypothyroidism and hyperthyroidism with positive TPOAb [RR (CI 95%): 1.99 (1.27-3.13) and 2.20 (1.23-3.95), respectively].
The incidence rate of thyroid dysfunction is high in Isfahan, and higher TPOAb concentration is its strong predictor.
伊朗伊斯法罕地区碘充足,但甲状腺功能障碍的患病率很高。本研究旨在调查大都市伊斯法罕成年人甲状腺功能障碍的发病率,并确定甲状腺自身抗体的作用。
在 2006 年至 2011 年的一项基于人群的队列研究中,我们测量了 618 名 2006 年甲状腺功能正常的 2254 人中的 TSH、T4、T3、甲状腺过氧化物酶抗体(TPOAb)和甲状腺球蛋白抗体(TgAb)。计算每 1000 人年(pr)的发病率。基于逻辑回归计算比值比(OR)、相对风险(RR)和 95%置信区间(95%CI),以量化甲状腺功能障碍的潜在预测因素。使用接收者操作特征(ROC)分析和曲线下面积(AUC)确定基线 TPOAb 和 TgAb 的最佳截断值,以预测甲状腺功能障碍。
在 6 年的随访中,女性的甲状腺功能减退症发病率为 3.3/1000 人年,男性为 2.1/1000 人年;而女性的甲状腺功能亢进症发病率为 3.8/1000 人年,男性无病例。获得 TPOAb 截断值为 38 IU/mL 以区分甲状腺功能减退症和甲状腺功能亢进症患者,特异性为 0.75,敏感性为 0.76,AUC(95%CI)为 0.882(0.743-1.02),P=0.01 和 0.817(0.600-1.035),P=0.033。甲状腺功能减退症和甲状腺功能亢进症与 TPOAb 阳性有统计学显著关联[RR(95%CI):1.99(1.27-3.13)和 2.20(1.23-3.95)]。
伊斯法罕甲状腺功能障碍的发病率很高,较高的 TPOAb 浓度是其强有力的预测指标。